Friday, August 21, 2015

Novartis to Buy Multiple Sclerosis Drug From Glaxo for $1 Billion by AMIE TSANG


By AMIE TSANG

The experimental drug ofatumumab would bolster the Swiss pharmaceutical company’s portfolio of multiple sclerosis treatments.

Published: August 22, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1NzuimJ



from WordPress http://ift.tt/1hPCymr
via Hadi Aboukhater

No comments:

Post a Comment